Please login to the form below

Not currently logged in
Email:
Password:

tocilizumab

This page shows the latest tocilizumab news and features for those working in and with pharma, biotech and healthcare.

Roche/Gilead tag team fights COVID-19 with Actemra/remdesivir

Roche/Gilead tag team fights COVID-19 with Actemra/remdesivir

The 450-patient phase 3 trial is pairing Gilead’s polymerase inhibitor remdesivir – designed to inhibit replication of the virus – with Roche’s IL-6 inhibitor Actemra/RoActemra (tocilizumab) which acts

Latest news

More from news
Approximately 7 fully matching, plus 52 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dovetail

About Dovetail We’re award-winning specialists in healthcare collaboration that makes patients’ lives better. Combining expertise with a passion for collaboration,...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics